Circulating levels of IGFBP7 have been strongly associated with hepatic IGFBP7 expression as well as with steatosis and fibrosis stage in patients with NAFLD. The gene discussed is IGFBP7; the disease is metabolic dysfunction-associated steatotic liver disease.